Cargando…

Brain metabolic signatures in patients with genetic and nongenetic amyotrophic lateral sclerosis

AIMS: To study the brain metabolic signature in Chinese amyotrophic lateral sclerosis (ALS) patients and compare the difference in brain metabolic patterns between ALS with and without genetic variants. METHODS: We included 146 patients with ALS and 128 healthy controls (HCs). All patients with ALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Pan, Tang, Yongxiang, Li, Wanzhen, Liu, Zhen, Zhou, Ming, Li, Jian, Yuan, Yanchun, Fang, Liangjuan, Guo, Jifeng, Shen, Lu, Jiang, Hong, Tang, Beisha, Hu, Shuo, Wang, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401109/
https://www.ncbi.nlm.nih.gov/pubmed/36971206
http://dx.doi.org/10.1111/cns.14193
Descripción
Sumario:AIMS: To study the brain metabolic signature in Chinese amyotrophic lateral sclerosis (ALS) patients and compare the difference in brain metabolic patterns between ALS with and without genetic variants. METHODS: We included 146 patients with ALS and 128 healthy controls (HCs). All patients with ALS underwent genetic testing to screen for ALS related genetic variants and were then divided into genetic (n = 22) and nongenetic ALS (n = 93) subgroups. All participants underwent brain (18)F‐FDG‐PET scans. Group comparisons were performed using the two‐sample t‐test model of SPM12. RESULTS: We identified a large of hypometabolic clusters in ALS patients as compared with HCs, especially in the bilateral basal ganglia, midbrain, and cerebellum. Moreover, hypometabolism in the bilateral temporal lobe, precentral gyrus and hypermetabolism in the left anterior cingulate, occipital lobe, and bilateral frontal lobe were also found in ALS patients as compared with HCs. Compared with nongenetic ALS patients, genetic ALS patients showed hypometabolism in the right postcentral gyrus, precuneus, and middle occipital gyrus. The incidence of sensory disturbance in patients with genetic ALS was higher than that in patients with nongenetic ALS (5 of 22 [22.72%] vs. 7 of 93 [7.52%], p = 0.036). CONCLUSIONS: Our investigation provided unprecedented evidence of relative hypometabolism in the midbrain and cerebellum in ALS patients. Genetic ALS patients showed a specific signature of brain metabolism and a higher incidence of sensory disturbance, indicating that genetic factors may be an underlying cause affecting the brain metabolism and increasing the risk of sensory disturbance in ALS.